COVID-19: In an unequal world, our response to COVID-19 cannot be one size-fits-all
December 4, 2021Dr Isabelle Defourny, MSF director of operations This opinion piece was first published in English in Al Jazeera and in French by Le Monde. Today we can say that we are entering into a new phase of the COVID-19 pandemic, with many of the countries that...
Read more
MSF to wealthy countries: Don’t block and ruin the potential of a landmark waiver on monopolies during the pandemic
February 3, 2021Geneva, Switzerland — Ahead of the next round of talks at the World Trade Organization (WTO) to discuss a proposal by South Africa and India to waive monopolies on COVID-19 medical tools during the pandemic, Médecins Sans Frontières/Doctors Without Borders...
Read more
Access to medicines: Will history repeat itself?
January 19, 2021Rebutting pharma’s rejection of a global COVID-19 IP waiver By Felipe Carvalho, Yuanqiong Hu, Leena Menghaney In response to the COVID-19 “TRIPS waiver” proposal submitted by South Africa and India for a temporary waiver from certain pharmaceutical intellectual property (IP) obligations at...
Read more
COVID-19: Governments must act fast on consensus supporting historic move to suspend monopolies during pandemic
December 15, 2020Over 100 countries support the landmark proposal Geneva —Ahead of a critical meeting at the World Trade Organization (WTO) tomorrow — and against the backdrop of COVID-19 cases surging globally — the international medical humanitarian organisation Médecins Sans Frontières /Doctors...
Read more
COVID-19: Pfizer and Moderna vaccines can only be scaled up globally if many more suppliers can produce
December 8, 2020Geneva – As the US Food and Drug Administration (FDA) starts meeting today and later this month to discuss emergency use authorisation of both the Pfizer/BioNTech and Moderna COVID-19 vaccine candidates, Médecins Sans Frontières/Doctors Without Borders (MSF) warns that any eventual...
Read more
MSF: Governments must demand pharma make all COVID-19 vaccine licensing deals public
November 11, 2020Terms of a deal disclosed show that we cannot rely on pharma’s goodwill to do the right thing, even in a pandemic. Geneva, 11 November 2020 – After the worrying terms of a deal struck between pharmaceutical corporation AstraZeneca and...
Read more
5 reasons a new proposal by India and South Africa could be a gamechanger in the COVID-19 response
October 11, 20205 reasons a new proposal by India and South Africa could be a gamechanger in the COVID-19 response. And why ALL governments should support it. On October 2, 2020, India and South Africa submitted a landmark proposal to the World Trade...
Read more
COVID-19 vaccine: 6 recommendations for equitable access
June 22, 2020We're in a time of unprecedented mobilisation to tackle COVID-19. We're in a time of unprecedented mobilisation to tackle COVID-19. Governments and philanthropies have contributed billions to the research and development of COVID-19 vaccines, while Gavi, the Vaccine Alliance, has recently launched...
Read more
